Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1981 1
1982 1
1990 1
1992 1
1995 1
1997 1
2013 1
2014 3
2015 4
2016 5
2017 6
2018 3
2019 6
2020 10
2021 4
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean n sarangi, (295 results)?
Gut microbiota-dependent trimethylamine N-oxide and all-cause mortality: Findings from an updated systematic review and meta-analysis.
Farhangi MA. Farhangi MA. Nutrition. 2020 Oct;78:110856. doi: 10.1016/j.nut.2020.110856. Epub 2020 May 17. Nutrition. 2020. PMID: 32592979 Review.
The gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) has been regarded as one of the potent risk factors for cardiovascular events and diabetes. ...
The gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) has been regarded as one of the potent risk factors for cardiovas …
Nanomedicine: New Frontiers in Fighting Microbial Infections.
Mehrabi MR, Soltani M, Chiani M, Raahemifar K, Farhangi A. Mehrabi MR, et al. Nanomaterials (Basel). 2023 Jan 25;13(3):483. doi: 10.3390/nano13030483. Nanomaterials (Basel). 2023. PMID: 36770443 Free PMC article. Review.
Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose-response meta-analysis.
Farhangi MA, Vajdi M, Asghari-Jafarabadi M. Farhangi MA, et al. Nutr J. 2020 Jul 30;19(1):76. doi: 10.1186/s12937-020-00592-2. Nutr J. 2020. PMID: 32731904 Free PMC article. Review.
AIMS: Several epidemiological studies have examined the association between trimethylamine N-Oxide (TMAO) and stroke risk; however, the results are still inconclusive. ...
AIMS: Several epidemiological studies have examined the association between trimethylamine N-Oxide (TMAO) and stroke risk; however, t …
The effect of calorie-restriction along with thylakoid membranes of spinach on the gut-brain Axis Pathway and oxidative stress biomarkers in obese women with polycystic ovary syndrome: a Randomized, Double-blind, placebo-controlled clinical trial.
Nikrad N, Farhangi MA, Fard Tabrizi FP, Vaezi M, Mahmoudpour A, Mesgari-Abbasi M. Nikrad N, et al. J Ovarian Res. 2023 Nov 16;16(1):216. doi: 10.1186/s13048-023-01288-x. J Ovarian Res. 2023. PMID: 37968684 Free PMC article. Clinical Trial.
METHODS: In this double-blind, randomized, placebo-controlled, and clinical trial, 48 women with obesity and diagnosed with PCOS based on Rotterdam criteria were randomly assigned to thylakoid (N = 21) and placebo groups (N = 23). A personalized hypocaloric diet wit …
METHODS: In this double-blind, randomized, placebo-controlled, and clinical trial, 48 women with obesity and diagnosed with PCOS based on Ro …
Characterization of the two unique human anti-flavin monoclonal immunoglobulins.
Stoppini M, Bellotti V, Negri A, Merlini G, Garver F, Ferri G. Stoppini M, et al. Eur J Biochem. 1995 Mar 15;228(3):886-93. doi: 10.1111/j.1432-1033.1995.tb20336.x. Eur J Biochem. 1995. PMID: 7737190 Free article.
Form A of two previously described human monoclonal anti-riboflavin IgGs, the GAR [Farhangi, M. & Osserman, E. F. (1976) N. Engl. J. Med. 294, 177-183] and DOT [Merlini, G., Bruening, R., Kyle, R. & Osserman, E. ...DOT and GAR do not form an adduct between t …
Form A of two previously described human monoclonal anti-riboflavin IgGs, the GAR [Farhangi, M. & Osserman, E. F. (1976) N …
Nature of the riboflavin interaction with the immunoglobulin IgGGAR: analogue binding studies.
Pologe LG, Goyal A, Greer J. Pologe LG, et al. Mol Immunol. 1982 Nov;19(11):1499-507. doi: 10.1016/0161-5890(82)90196-1. Mol Immunol. 1982. PMID: 7183913
The human immunoglobulin IgGGAR has been shown to bind riboflavin both in vivo and in vitro with a high binding constant [Farhangi & Osserman (1976), New Engl. J. Med. 294, 177-183; Chang et al. (1981b), Biochemistry 20, 2916-2921; Chang et al. (1981a), Biochemistry 20 …
The human immunoglobulin IgGGAR has been shown to bind riboflavin both in vivo and in vitro with a high binding constant [Farhangi &a …
Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta- analysis.
Dehghan P, Farhangi MA, Nikniaz L, Nikniaz Z, Asghari-Jafarabadi M. Dehghan P, et al. Obes Rev. 2020 May;21(5):e12993. doi: 10.1111/obr.12993. Epub 2020 Feb 3. Obes Rev. 2020. PMID: 32017391
It has been suggested that trimethylamine N-oxide (TMAO) is associated with increased risk of diabetes and cardiovascular disease (CVD) morbidity and mortality. ...
It has been suggested that trimethylamine N-oxide (TMAO) is associated with increased risk of diabetes and cardiovascular disease (CV …
Further studies of the riboflavin-binding immunoglobulin IgGGar. Resolution into fractions of different riboflavin content and aspects of reassembly.
Chang MY, Friedman FK, Beychok S, Shyong JS, Osserman EF. Chang MY, et al. Biochemistry. 1981 May 12;20(10):2916-21. doi: 10.1021/bi00513a031. Biochemistry. 1981. PMID: 7248257
A previously described human immunoglobulin with unusual flavin-binding activity, IgGGar [Farhangi, M., & Osserman, E. F. (1976) N. Engl. J. Med. 294, 177], is further characterized. ...
A previously described human immunoglobulin with unusual flavin-binding activity, IgGGar [Farhangi, M., & Osserman, E. F. (1976) …
47 results